Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-052627
Filing Date
2025-04-10
Accepted
2025-04-09 19:45:33
Documents
6
Period of Report
2025-04-09

Document Format Files

Seq Description Document Type Size
1 6-K press_release_april_9_20.htm 6-K 27314
2 EX-99.1 ipa-ex99_1.htm EX-99.1 19881
3 EX-99.2 ipa-ex99_2.htm EX-99.2 5388
4 EX-99.3 ipa-ex99_3.htm EX-99.3 12862
5 EX-99.4 ipa-ex99_4.htm EX-99.4 7108
6 EX-99.5 ipa-ex99_5.htm EX-99.5 5633
  Complete submission text file 0000950170-25-052627.txt   79240
Mailing Address INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300 AUSTIN TX 78701
Business Address INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300 AUSTIN TX 78701 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 25826224
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)